Novo Nordisk says it is gradually phasing out human insulin pens globally
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
health-e10h
MSF condemns Novo Nordisk double standard in diabetes care
The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.
Why maker of ‘magic’ weight-loss drug semaglutide wants copies banned
US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...
Weight loss drugs Ozempic and Wegovy may also curb alcohol addiction, study says
A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...